Cargando…

Biejiajian Pill Ameliorates Diabetes-Associated Atherosclerosis through Inhibition of the NLRP3 Inflammasome

OBJECTIVE: To research the efficacy of Biejiajian pill (BJJ) on diabetes-associated atherosclerosis and explore its subsequent mechanisms. METHODS: Diabetes-associated atherosclerosis (AS) was established in apolipoprotein E knockout (ApoE(−/−)) mice using high-fat diet and streptozotocin. Atorvasta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Yu, Yuan, Jiayao, Sang, Feng, Shao, Mingyi, Yan, Shuxun, Li, Leilei, Zhu, Rong, Wang, Zhongrui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184231/ https://www.ncbi.nlm.nih.gov/pubmed/35692570 http://dx.doi.org/10.1155/2022/9131178

Ejemplares similares

Potential Mechanisms of Biejiajian Pill in the Treatment of Diabetic Atherosclerosis Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation
por: Zhu, Rong, et al.
Publicado: (2022)

Biejiajian Pill Inhibits Carcinogenesis and Metastasis via the Akt/GSK-3β/Snail Signaling Pathway in Hepatocellular Carcinoma
por: Sun, Jialing, et al.
Publicado: (2021)

Biejiajian Pill Promotes the Infiltration of CD8(+) T Cells in Hepatocellular Carcinoma by Regulating the Expression of CCL5
por: Yang, Xuemei, et al.
Publicado: (2021)

Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition
por: Ma, Sai, et al.
Publicado: (2018)

Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice
por: Zhao, Jingfei, et al.
Publicado: (2020)

Celastrol ameliorates inflammation through inhibition of NLRP3 inflammasome activation
por: Yu, Xianjun, et al.
Publicado: (2017)

Novel Insights Into the NLRP3 Inflammasome in Atherosclerosis
por: Jin, Ying, et al.
Publicado: (2019)

Role of NLRP3 Inflammasomes in Atherosclerosis
por: Karasawa, Tadayoshi, et al.
Publicado: (2017)

Ketogenic diet ameliorates inflammation by inhibiting the NLRP3 inflammasome in osteoarthritis
por: Kong, Ganggang, et al.
Publicado: (2022)

Pyroptosis in NLRP3 inflammasome-related atherosclerosis
por: Zeng, Xiang, et al.
Publicado: (2022)

Meta-analysis of influences of Biejiajian Pill combined with entecavir on serum liver fibrosis markers of compensatory period of hepatitis b cirrhosis: Protocol of systematic review and meta-analysis
por: Zhang, Tianyao, et al.
Publicado: (2019)

Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages
por: Ke, Ping, et al.
Publicado: (2016)

GPA peptide inhibits NLRP3 inflammasome activation to ameliorate colitis through AMPK pathway
por: Deng, Zhao, et al.
Publicado: (2020)

Ruscogenin Ameliorated Sjögren's Syndrome by Inhibiting NLRP3 Inflammasome Activation
por: He, Jing, et al.
Publicado: (2022)

Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation
por: Wen, Jiexia, et al.
Publicado: (2020)

The crystal-induced activation of NLRP3 inflammasomes in atherosclerosis
por: Karasawa, Tadayoshi, et al.
Publicado: (2017)

NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis
por: Paramel Varghese, Geena, et al.
Publicado: (2016)

Salvianolic Acid A Ameliorates Early-Stage Atherosclerosis Development by Inhibiting NLRP3 Inflammasome Activation in Zucker Diabetic Fatty Rats
por: Ma, Quanxin, et al.
Publicado: (2020)

Apigenin attenuates atherosclerosis and non-alcoholic fatty liver disease through inhibition of NLRP3 inflammasome in mice
por: Lu, Zheng, et al.
Publicado: (2023)

Oridonin ameliorates carbon tetrachloride‐induced liver fibrosis in mice through inhibition of the NLRP3 inflammasome
por: Liu, Dong, et al.
Publicado: (2020)

4-Methylesculetin ameliorates LPS-induced depression-like behavior through the inhibition of NLRP3 inflammasome
por: Choudhary, Khushboo, et al.
Publicado: (2023)

Delayed NLRP3 inflammasome inhibition ameliorates subacute stroke progression in mice
por: Bellut, Maximilian, et al.
Publicado: (2023)

Sinapine Thiocyanate Ameliorates Vascular Endothelial Dysfunction in Hypertension by Inhibiting Activation of the NLRP3 Inflammasome
por: Liu, Yang, et al.
Publicado: (2021)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

Spotlight on NLRP3 Inflammasome: Role in Pathogenesis and Therapies of Atherosclerosis
por: Jiang, Chunteng, et al.
Publicado: (2021)

Neuroprotective Effects of Qingnao Dripping Pills Against Cerebral Ischemia via Inhibiting NLRP3 Inflammasome Signaling Pathway: In Vivo and In Vitro
por: Fu, Chen, et al.
Publicado: (2020)

Anti-malarial artesunate ameliorates atherosclerosis by modulating arterial inflammatory responses via inhibiting the NF-κB–NLRP3 inflammasome pathway
por: Cen, Yanyan, et al.
Publicado: (2023)

Simiao pill inhibits epithelial mesenchymal transition in a mouse model of chronic hyperuricemic nephropathy by inhibiting NLRP3 inflammasome activation
por: Shui, Guangxing, et al.
Publicado: (2022)

Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation
por: Wang, Shaofei, et al.
Publicado: (2017)

Ameliorative Effects of Cardamonin on Monosodium Urate-Induced Gouty Arthritis through Inhibiting NLRP3 Inflammasome Mediation
por: Wang, Chih-Chien, et al.
Publicado: (2021)

Inhibition of NLRP3 Inflammasome Ameliorates Cerebral Ischemia-Reperfusion Injury in Diabetic Mice
por: Hong, Pu, et al.
Publicado: (2018)

Melatonin ameliorates hepatic steatosis by inhibiting NLRP3 inflammasome in db/db mice
por: Yu, Yongxiang, et al.
Publicado: (2021)

Inhibition of the NLRP3 Inflammasome Activation by Manoalide Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis
por: Li, Cong, et al.
Publicado: (2022)

Genetic deletion or pharmacologic inhibition of the Nlrp3 inflammasome did not ameliorate experimental NASH
por: Ioannou, George N., et al.
Publicado: (2023)

Activating α7nAChR ameliorates abdominal aortic aneurysm through inhibiting pyroptosis mediated by NLRP3 inflammasome
por: Fu, Hui, et al.
Publicado: (2022)

NLRP3 inflammasome: a novel link between lipoproteins and atherosclerosis
por: Li, Wang Li, et al.
Publicado: (2016)

NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis
por: Wan, Zhaofei, et al.
Publicado: (2019)

NLRP3 Inflammasome: A Potential Alternative Therapy Target for Atherosclerosis
por: Liu, Yang, et al.
Publicado: (2020)

Interactions between PCSK9 and NLRP3 inflammasome signaling in atherosclerosis
por: Wang, Yanan, et al.
Publicado: (2023)

Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets
por: Tanase, Daniela Maria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2pqtpr47lkbpofjh9ivk30aqed